Dopamine reuptake site densities in patients with social phobia
OBJECTIVE: It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake s...
Saved in:
Published in | The American journal of psychiatry Vol. 154; no. 2; pp. 239 - 242 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Washington, DC
American Psychiatric Publishing
01.02.1997
American Psychiatric Association |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | OBJECTIVE: It has been suggested that social phobia is associated with
dysfunction of the noradrenergic and dopaminergic systems, but there are no
published anatomic data on the monoaminergic abnormalities found in the
brains of phobic patients. The authors studied the density of dopamine
reuptake sites in patients with social phobia. METHOD: The study included
11 patients with social phobia and 28 healthy comparison subjects, 11 of
whom were age- and gender-matched to the patients for the analyses.
Measurement of the density of dopamine reuptake sites was performed by
using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon
emission computed tomography (SPECT). RESULTS: Blind quantitative analysis
revealed that striatal dopamine reuptake site densities were markedly lower
in the patients with social phobia than in the age- and gender-matched
comparison subjects. CONCLUSIONS: The results indicate that social phobia
may be associated with a dysfunction of the striatal dopaminergic
system. |
---|---|
AbstractList | OBJECTIVE: It has been suggested that social phobia is associated with
dysfunction of the noradrenergic and dopaminergic systems, but there are no
published anatomic data on the monoaminergic abnormalities found in the
brains of phobic patients. The authors studied the density of dopamine
reuptake sites in patients with social phobia. METHOD: The study included
11 patients with social phobia and 28 healthy comparison subjects, 11 of
whom were age- and gender-matched to the patients for the analyses.
Measurement of the density of dopamine reuptake sites was performed by
using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon
emission computed tomography (SPECT). RESULTS: Blind quantitative analysis
revealed that striatal dopamine reuptake site densities were markedly lower
in the patients with social phobia than in the age- and gender-matched
comparison subjects. CONCLUSIONS: The results indicate that social phobia
may be associated with a dysfunction of the striatal dopaminergic
system. It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia.OBJECTIVEIt has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia.The study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT).METHODThe study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT).Blind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects.RESULTSBlind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects.The results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system.CONCLUSIONSThe results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system. It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia. The study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT). Blind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects. The results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system. It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data on the monoaminergic abnormalities found in the brains of phobic patients. The authors studied the density of dopamine reuptake sites in patients with social phobia. The study included 11 patients with social phobia and 28 healthy comparison subjects, 11 of whom were age- and gender-matched to the patients for the analyses. Measurement of the density of dopamine reuptake sites was performed by using a 123I-labeled cocaine analogue, [123I]beta-CIT, with single photon emission computed tomography (SPECT). Blind quantitative analysis revealed that striatal dopamine reuptake site densities were markedly lower in the patients with social phobia than in the age- and gender-matched comparison subjects. The results indicate that social phobia may be associated with a dysfunction of the striatal dopaminergic system. |
Author | TIIHONEN, J BERGSTRÖM, K LEPOLA, U KUIKKA, J LEINONEN, E KOPONEN, H |
Author_xml | – sequence: 1 givenname: J surname: TIIHONEN fullname: TIIHONEN, J organization: Department of Clinical Psychiatry, University of Kuopio, Finland – sequence: 2 givenname: J surname: KUIKKA fullname: KUIKKA, J organization: Department of Clinical Psychiatry, University of Kuopio, Finland – sequence: 3 givenname: K surname: BERGSTRÖM fullname: BERGSTRÖM, K organization: Department of Clinical Psychiatry, University of Kuopio, Finland – sequence: 4 givenname: U surname: LEPOLA fullname: LEPOLA, U organization: Department of Clinical Psychiatry, University of Kuopio, Finland – sequence: 5 givenname: H surname: KOPONEN fullname: KOPONEN, H organization: Department of Clinical Psychiatry, University of Kuopio, Finland – sequence: 6 givenname: E surname: LEINONEN fullname: LEINONEN, E organization: Department of Clinical Psychiatry, University of Kuopio, Finland |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2560232$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/9016274$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc2LFDEQxYOsrLOrR49Co-JB6DGVj073SWT9hAUvCt5CdXc1m7EniUk34n9vhhkWWdxTJbzfq6rkXbAzHzwx9hT4FsA0b3AXt6DVVmyF7B6wDWipayNEe8Y2nHNRd1r-eMQuct6VK5dGnLPzjkMjjNqwt-9DxL3zVCVa44I_qcpuoWokX6qjXDlfRSwnv-Tqt1tuqhwGh3MVb0Lv8DF7OOGc6cmpXrLvHz98u_pcX3_99OXq3XWNipulBoU0QNtNBJM2PZQteg4GemmUHFpq2r5TuqhjY3hxQIM0Ao6kJYytVPKSvTr2jSn8Wikvdu_yQPOMnsKarWlb4J0yBXx-B9yFNfmymxWCF0A1okAv7oNAQytF17UH6tmJWvs9jTYmt8f0x54-r-gvTzrmAecpoR9cvsWEbriQhzb1ERtSyDnRdEsAt4cIbYmwzFVW2BJh4eUdfnBLSSD4JaGb73W9ProwRvfPc_4L_wVSvapq |
CODEN | AJPSAO |
CitedBy_id | crossref_primary_10_1016_S0165_1781_98_00117_6 crossref_primary_10_1016_j_sjpain_2011_06_004 crossref_primary_10_1176_appi_ajp_160_5_904 crossref_primary_10_1016_j_neuropharm_2018_12_016 crossref_primary_10_1016_j_janxdis_2010_02_002 crossref_primary_10_1111_j_1749_6632_2003_tb07095_x crossref_primary_10_1016_j_pnpbp_2007_06_027 crossref_primary_10_3389_fnins_2020_00154 crossref_primary_10_1016_j_neuroscience_2023_09_008 crossref_primary_10_1016_S0165_0327_98_00094_9 crossref_primary_10_1034_j_1600_0447_2001_00090_x crossref_primary_10_1016_S0014_2999_03_01275_5 crossref_primary_10_1016_j_bbr_2009_06_009 crossref_primary_10_1016_j_cpr_2006_12_003 crossref_primary_10_1017_S0033291717001076 crossref_primary_10_1177_1073191116654003 crossref_primary_10_1038_s41398_023_02708_8 crossref_primary_10_1177_0269881112450778 crossref_primary_10_1016_j_jns_2016_12_062 crossref_primary_10_1016_S1077_7229_01_80005_5 crossref_primary_10_1016_j_cpet_2007_09_005 crossref_primary_10_1016_S0306_4522_03_00032_0 crossref_primary_10_5694_j_1326_5377_1998_tb126710_x crossref_primary_10_1016_j_pain_2012_01_002 crossref_primary_10_1176_appi_ajp_158_2_327_a crossref_primary_10_1016_j_comppsych_2017_12_002 crossref_primary_10_1016_S0013_7006_04_95442_5 crossref_primary_10_1177_2045125317714193 crossref_primary_10_1016_j_jpsychires_2009_04_014 crossref_primary_10_1016_j_pnpbp_2014_12_008 crossref_primary_10_1016_j_nicl_2017_08_001 crossref_primary_10_1590_S0100_879X2002000800013 crossref_primary_10_1002_syn_20746 crossref_primary_10_1017_S1092852900027267 crossref_primary_10_1016_S0006_3223_01_01268_9 crossref_primary_10_1034_j_1600_0447_108_s417_4_x crossref_primary_10_1017_S0954579413000941 crossref_primary_10_1016_j_bbr_2018_10_028 crossref_primary_10_1016_j_pscychresns_2006_03_001 crossref_primary_10_1016_S0006_3223_98_00265_0 crossref_primary_10_1016_j_bbr_2008_08_047 crossref_primary_10_1016_j_yhbeh_2011_08_013 crossref_primary_10_1016_S0301_0082_03_00087_X crossref_primary_10_1016_j_pnpbp_2010_02_028 crossref_primary_10_1002_da_20543 crossref_primary_10_1016_j_neurobiolaging_2017_05_006 crossref_primary_10_1016_j_pscychresns_2009_04_006 crossref_primary_10_1177_0269881108098144 crossref_primary_10_1016_S0278_5846_99_00109_8 crossref_primary_10_1177_0003065109333502 crossref_primary_10_2967_jnumed_107_045518 crossref_primary_10_1016_j_pnpbp_2007_04_020 crossref_primary_10_1017_S1092852900028066 crossref_primary_10_1093_scan_nsw149 crossref_primary_10_1176_jnp_14_4_438 crossref_primary_10_1016_j_neulet_2019_134443 crossref_primary_10_1016_j_yebeh_2014_01_001 crossref_primary_10_2967_jnumed_118_212795 crossref_primary_10_1016_S0160_2527_00_00059_5 crossref_primary_10_1073_pnas_1518825113 crossref_primary_10_1017_S109285291400008X crossref_primary_10_1111_spc3_12515 crossref_primary_10_1067_mai_2001_114798 crossref_primary_10_1017_S1092852900010361 crossref_primary_10_1017_S1092852900015534 crossref_primary_10_1111_j_1528_1157_1999_tb00935_x crossref_primary_10_1111_j_1742_7843_2007_00145_x crossref_primary_10_1176_appi_ajp_157_5_834_a crossref_primary_10_1038_s41398_022_02187_3 crossref_primary_10_1016_j_baga_2012_06_004 crossref_primary_10_1034_j_1600_0447_2001_0008a_x crossref_primary_10_19127_mbsjohs_676960 crossref_primary_10_1002__SICI_1098_2396_199803_28_3_244__AID_SYN7_3_0_CO_2_A crossref_primary_10_1371_journal_pone_0017405 crossref_primary_10_1176_appi_ajp_157_3_457 crossref_primary_10_1016_j_comppsych_2012_03_002 crossref_primary_10_1016_S0193_953X_02_00018_7 crossref_primary_10_1016_j_neuroscience_2019_07_026 crossref_primary_10_1016_j_jns_2011_06_056 crossref_primary_10_1590_1516_4446_2021_1926 crossref_primary_10_1016_j_euroneuro_2017_03_007 crossref_primary_10_1017_S1092852900012499 crossref_primary_10_1176_appi_ajp_158_10_1558 crossref_primary_10_1080_10673220600748536 crossref_primary_10_1016_j_biopsych_2006_05_043 crossref_primary_10_1016_S0165_1781_02_00103_8 crossref_primary_10_3389_fnins_2020_608520 crossref_primary_10_1016_S0165_0327_99_00140_8 crossref_primary_10_1111_j_1749_6632_2003_tb07096_x crossref_primary_10_1517_13543776_13_4_401 crossref_primary_10_1126_science_1120972 crossref_primary_10_3109_07853899809005851 crossref_primary_10_1002_jnr_21642 crossref_primary_10_1016_j_nic_2006_06_003 crossref_primary_10_1093_scan_nst129 crossref_primary_10_1176_foc_9_3_foc311 crossref_primary_10_1016_S0025_7125_05_70337_0 crossref_primary_10_31363_2313_7053_2019_2_3_12 crossref_primary_10_1515_revneuro_2018_0037 crossref_primary_10_1016_S0140_6736_08_60488_2 crossref_primary_10_1590_S1516_44462002000100012 crossref_primary_10_1017_S1092852900021635 crossref_primary_10_1523_JNEUROSCI_2382_18_2019 crossref_primary_10_1016_j_bbrc_2018_03_162 crossref_primary_10_1016_S0193_953X_05_70259_8 crossref_primary_10_1016_j_psychres_2005_05_004 crossref_primary_10_1016_j_neubiorev_2011_08_002 crossref_primary_10_1016_S0025_7125_05_70329_1 crossref_primary_10_1176_appi_ajp_161_1_59 crossref_primary_10_1007_s00018_020_03649_x |
Cites_doi | 10.1002/syn.890160203 10.1016/0278-5846(92)90020-F 10.1097/00006231-199306000-00013 10.1038/ng0196-78 10.1007/BF00941852 10.1016/0166-2236(92)90068-J 10.1001/archpsyc.1994.03950120047008 10.1038/ng0196-81 10.1001/archpsyc.1994.03950080019003 10.1176/ajp.138.12.1572 10.1001/archpsyc.1994.03950010008002 10.1007/BF01245007 10.1007/BF00182306 10.1097/00004714-198604000-00006 10.1097/00004714-198808000-00008 10.1038/nm0795-654 10.1038/jcbfm.1993.39 10.1192/bjp.161.3.353 10.1001/archpsyc.1984.01790210041006 10.1073/pnas.90.24.11965 10.1037/e591322011-001 10.1016/1353-8020(95)00012-U 10.1007/BF00180909 |
ContentType | Journal Article |
Copyright | 1997 INIST-CNRS Copyright American Psychiatric Association Feb 1997 |
Copyright_xml | – notice: 1997 INIST-CNRS – notice: Copyright American Psychiatric Association Feb 1997 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM HAWNG HBMBR IBDFT K30 PAAUG PAWHS PAWZZ PAXOH PBHAV PBQSW PBYQZ PCIWU PCMID PCZJX PDGRG PDWWI PETMR PFVGT PGXDX PIHIL PISVA PJCTQ PJTMS PLCHJ PMHAD PNQDJ POUND PPLAD PQAPC PQCAN PQCMW PQEME PQHKH PQMID PQNCT PQNET PQSCT PQSET PSVJG PVMQY PZGFC K9. NAPCQ 7X8 |
DOI | 10.1176/ajp.154.2.239 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Periodicals Index Online Segment 13 Periodicals Index Online Segment 14 Periodicals Index Online Segment 27 Periodicals Index Online Primary Sources Access—Foundation Edition (Plan E) - West Primary Sources Access (Plan D) - International Primary Sources Access & Build (Plan A) - MEA Primary Sources Access—Foundation Edition (Plan E) - Midwest Primary Sources Access—Foundation Edition (Plan E) - Northeast Primary Sources Access (Plan D) - Southeast Primary Sources Access (Plan D) - North Central Primary Sources Access—Foundation Edition (Plan E) - Southeast Primary Sources Access (Plan D) - South Central Primary Sources Access & Build (Plan A) - UK / I Primary Sources Access (Plan D) - Canada Primary Sources Access (Plan D) - EMEALA Primary Sources Access—Foundation Edition (Plan E) - North Central Primary Sources Access—Foundation Edition (Plan E) - South Central Primary Sources Access & Build (Plan A) - International Primary Sources Access—Foundation Edition (Plan E) - International Primary Sources Access (Plan D) - West Periodicals Index Online Segments 1-50 Primary Sources Access (Plan D) - APAC Primary Sources Access (Plan D) - Midwest Primary Sources Access (Plan D) - MEA Primary Sources Access—Foundation Edition (Plan E) - Canada Primary Sources Access—Foundation Edition (Plan E) - UK / I Primary Sources Access—Foundation Edition (Plan E) - EMEALA Primary Sources Access & Build (Plan A) - APAC Primary Sources Access & Build (Plan A) - Canada Primary Sources Access & Build (Plan A) - West Primary Sources Access & Build (Plan A) - EMEALA Primary Sources Access (Plan D) - Northeast Primary Sources Access & Build (Plan A) - Midwest Primary Sources Access & Build (Plan A) - North Central Primary Sources Access & Build (Plan A) - Northeast Primary Sources Access & Build (Plan A) - South Central Primary Sources Access & Build (Plan A) - Southeast Primary Sources Access (Plan D) - UK / I Primary Sources Access—Foundation Edition (Plan E) - APAC Primary Sources Access—Foundation Edition (Plan E) - MEA ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Periodicals Index Online Segment 14 Periodicals Index Online Segments 1-50 Periodicals Index Online Segment 27 Periodicals Index Online Periodicals Index Online Segment 13 ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-7228 |
EndPage | 242 |
ExternalDocumentID | 11056542 9016274 2560232 10_1176_ajp_154_2_239 10.1176/ajp.154.2.239 |
Genre | Journal Article |
GroupedDBID | --- --Z -DZ -~X .55 .GJ 08R 0WA 1HT 1KJ 1QT 23M 2WC 3O- 4.4 53G 5GY 5RE 6J9 7K8 85S 8R4 8R5 AAAHA AAIKC AAJWC AAMNW AAPBV AAWTL AAWTO ABFLS ABIVO ABPPZ ABPTK ABZEH ACBMB ACGFO ACGOD ACHQT ACNCT ADBBV ADCOW ADMHG AENEX AETEA AFAZI AFFNX AFMIJ AFOSN AGNAY AHMBA AI. AJKYJ ALMA_UNASSIGNED_HOLDINGS ASUFR BAJDF BAWUL BENPR BKOMP CS3 DIK E3Z EBS EJD EX3 F20 F5P F8P FA8 FJW G0H G8K H13 HF~ HZ~ J5H L7B MVM N4W N9A NEJ NHB OHT OK1 OVD P-O P2P PQEST PQQKQ Q.- Q2X RAY RXW RYA S10 SJN SKT TAE TEORI TR2 TWZ UHB UKR ULE UPT UQL VH1 VVN WH7 WHG WOQ WOW X4V X6Y X7M XJT XOL XSW XZL YCJ YFH YOC YWH YZZ ZA5 ZCA ZGI ZHY ZRR ZXP ZY1 ~A~ ~G0 AAJMC AAYXX ABDPE AGHSJ CITATION 08P 1CY 2QL 354 41~ 6TJ 8F7 AAKAS AAQQT AAUGY AAYJJ ADZCM AERZD AFFDN AHJKT AKALU BCR BLC GOZPB GRPMH IQODW LXL LXN PEA RWL UBC YQI YQJ YRY YSK YXB YYQ ZKB ~X8 AIZTS CGR CUY CVF ECM EIF LPU NPM VXZ YIF YIN Z5M HAWNG HBMBR IBDFT K30 PAAUG PAWHS PAWZZ PAXOH PBHAV PBQSW PBYQZ PCIWU PCMID PCZJX PDGRG PDWWI PETMR PFVGT PGXDX PIHIL PISVA PJCTQ PJTMS PLCHJ PMHAD PNQDJ POUND PPLAD PQAPC PQCAN PQCMW PQEME PQHKH PQMID PQNCT PQNET PQSCT PQSET PSVJG PVMQY PZGFC ADXHL K9. NAPCQ 7X8 |
ID | FETCH-LOGICAL-a407t-14aec189fe1f57b1372b0171b3743c8e68b945fe1d67040716aed1ade531d8343 |
ISSN | 0002-953X |
IngestDate | Thu Jul 10 20:02:29 EDT 2025 Tue Aug 12 03:55:02 EDT 2025 Mon Jun 30 16:00:48 EDT 2025 Wed Feb 19 01:23:52 EST 2025 Sun Oct 22 16:04:27 EDT 2023 Thu Apr 24 23:12:24 EDT 2025 Tue Jul 01 04:08:59 EDT 2025 Fri Oct 28 07:32:04 EDT 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Human Dopamine Reuptake site Social phobia Central nervous system Anxiety disorder Neurotransmitter Corpus striatum Brain (vertebrata) |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-a407t-14aec189fe1f57b1372b0171b3743c8e68b945fe1d67040716aed1ade531d8343 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
PMID | 9016274 |
PQID | 1518329982 |
PQPubID | 1816671 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_78810947 proquest_journals_220473462 proquest_journals_1518329982 pubmed_primary_9016274 pascalfrancis_primary_2560232 crossref_primary_10_1176_ajp_154_2_239 crossref_citationtrail_10_1176_ajp_154_2_239 appi_journals_10_1176_ajp_154_2_239 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 1997-02-01 |
PublicationDateYYYYMMDD | 1997-02-01 |
PublicationDate_xml | – month: 02 year: 1997 text: 1997-02-01 day: 01 |
PublicationDecade | 1990 |
PublicationPlace | Washington, DC |
PublicationPlace_xml | – name: Washington, DC – name: United States – name: Washington, D.C – name: Washington |
PublicationTitle | The American journal of psychiatry |
PublicationTitleAlternate | Am J Psychiatry |
PublicationYear | 1997 |
Publisher | American Psychiatric Publishing American Psychiatric Association |
Publisher_xml | – name: American Psychiatric Publishing – name: American Psychiatric Association |
References | p_28 p_29 p_23 p_24 p_25 p_26 Bandecchi A (p_27) 1994; 10 p_20 p_21 p_16 p_17 p_18 p_1 p_19 p_4 p_3 p_13 p_6 p_14 p_15 p_7 p_9 Cloninger (p_12) 1994 Bergström KA (p_22) 1994; 38 Liebowitz MR (p_8) 1988; 49 Stein MB (p_2) 1994; 152 p_10 Uhde TW (p_5) 1991; 52 p_11 11156831 - Am J Psychiatry. 2001 Feb;158(2):327-8 |
References_xml | – ident: p_17 doi: 10.1002/syn.890160203 – ident: p_11 doi: 10.1016/0278-5846(92)90020-F – ident: p_21 doi: 10.1097/00006231-199306000-00013 – ident: p_13 doi: 10.1038/ng0196-78 – ident: p_23 doi: 10.1007/BF00941852 – ident: p_15 doi: 10.1016/0166-2236(92)90068-J – volume: 152 start-page: 408 year: 1994 ident: p_2 publication-title: Am J Psychiatry – ident: p_4 doi: 10.1001/archpsyc.1994.03950120047008 – volume: 52 start-page: 31 year: 1991 ident: p_5 publication-title: J Clin Psychiatry – ident: p_14 doi: 10.1038/ng0196-81 – ident: p_29 doi: 10.1001/archpsyc.1994.03950080019003 – ident: p_10 doi: 10.1176/ajp.138.12.1572 – volume: 38 start-page: 128 year: 1994 ident: p_22 publication-title: J Nucl Biol Med – ident: p_3 doi: 10.1001/archpsyc.1994.03950010008002 – ident: p_18 doi: 10.1007/BF01245007 – ident: p_20 doi: 10.1007/BF00182306 – ident: p_6 doi: 10.1097/00004714-198604000-00006 – ident: p_7 doi: 10.1097/00004714-198808000-00008 – ident: p_24 doi: 10.1038/nm0795-654 – volume: 49 start-page: 252 year: 1988 ident: p_8 publication-title: J Clin Psychiatry – ident: p_28 doi: 10.1038/jcbfm.1993.39 – ident: p_9 doi: 10.1192/bjp.161.3.353 – ident: p_1 doi: 10.1001/archpsyc.1984.01790210041006 – ident: p_19 doi: 10.1073/pnas.90.24.11965 – ident: p_26 doi: 10.1037/e591322011-001 – ident: p_25 doi: 10.1016/1353-8020(95)00012-U – ident: p_16 doi: 10.1007/BF00180909 – volume-title: The Temperament and Character Inventory (TCI): A Guide to its Development and Use. St Louis year: 1994 ident: p_12 – volume: 10 start-page: 725S year: 1994 ident: p_27 publication-title: Neuropsychopharmacology – reference: 11156831 - Am J Psychiatry. 2001 Feb;158(2):327-8 |
SSID | ssj0000372 |
Score | 1.9985242 |
Snippet | OBJECTIVE: It has been suggested that social phobia is associated with
dysfunction of the noradrenergic and dopaminergic systems, but there are no
published... It has been suggested that social phobia is associated with dysfunction of the noradrenergic and dopaminergic systems, but there are no published anatomic data... |
SourceID | proquest pubmed pascalfrancis crossref appi |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 239 |
SubjectTerms | Adult Adult and adolescent clinical studies Aged Anxiety disorders. Neuroses Biological and medical sciences Brain Brain - diagnostic imaging Brain Chemistry Carrier Proteins - metabolism Cocaine - analogs & derivatives Corpus Striatum - chemistry Corpus Striatum - diagnostic imaging Dopamine - analysis Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors - therapeutic use Fear & phobias Female Humans Male Medical sciences Membrane Glycoproteins Membrane Transport Proteins Middle Aged Nerve Tissue Proteins Neurology Neurons Phobia Phobic Disorders - diagnosis Phobic Disorders - diagnostic imaging Psychiatry Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Tomography, Emission-Computed, Single-Photon |
Title | Dopamine reuptake site densities in patients with social phobia |
URI | http://dx.doi.org/10.1176/ajp.154.2.239 https://www.ncbi.nlm.nih.gov/pubmed/9016274 https://www.proquest.com/docview/1518329982 https://www.proquest.com/docview/220473462 https://www.proquest.com/docview/78810947 |
Volume | 154 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLZgSAgJIW4T3QUsgXgZHc3VzhPaGGhjl0bQSttT5CQOzbqlUZM-wK_n-JY0KkXAS1TZruP4fD4-xz4XhN4MaOqwxI_7wksTHiDDBZkgCAtoHPA4ITJbw_mFfzx2v1x6l60pr_QuqeP95Odv_Ur-h6pQBnQVXrL_QNmmUyiA30BfeAKF4flXND4CjfdWiIlf-aKs2ZTvfQMJEnhIUclAqeIwI1SBU4Wdaz3Z09644WQW52xZMB21HibFcjiJrjW0MtjNJ7NC-3SApt1eBuXTqbK8_TGfNsWHfP69quWF_KEvwXea35rKMxD_b-R_xir5kT6BUNFbu9YcZnChGVGerICrZb-BJxMAt-xXBZHWOLOXmakKc7TK5ImMbnxdqmOxfd2uG0w7PBhG4ckwGl6cXd1F92zQIkSCi6OT03ajdohttCMxKhOClfjvO53Dbs3KMu9ILg9LVsEiylT2k_XqiRRTRo_RI61f4AMFlifoDi-eovvn2oLiGfpgMIMNZrDADG4wg_MCG8xggRmsMIMVZp6j8edPo4_HfZ1Eo89AV6_7lst4YtEg41bmkdiCb45FjKTYAdkxodyHJel6UJv6ZCC0e5_x1GIpB-acUsd1NtFGAah6gbBDszT2SEJBpXATEGpcK01JRjMCPVKP9NBrMU-RBmkVSQWT-BHMZgSzGdkRzGYPvTPTGCU6Dr1Ih3KzrvnbpnmpArCsa7jboUnTWgj1oDf00I6h0dIIPbGlBQGF6u3VatseuMRxfah91dQC_xWXaqzgs0UViXQMg8CFj99UdG_eC5K2SGy19ef3bqMH7ZraQRv1fMF3Qc6t45cSrb8A0PGnCg |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Dopamine+Reuptake+Site+Densities+in+Patients+With+Social+Phobia&rft.jtitle=The+American+journal+of+psychiatry&rft.au=Tiihonen%2C+Jari&rft.au=Kuikka%2C+Jyrki&rft.au=Bergstr%C3%B6m%2C+Kim&rft.au=Lepola%2C+Ulla&rft.date=1997-02-01&rft.pub=American+Psychiatric+Association&rft.issn=0002-953X&rft.volume=154&rft.issue=2&rft.spage=239&rft_id=info:doi/10.1176%2Fajp.154.2.239&rft.externalDBID=PAO_PIO_ONLY |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-953X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-953X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-953X&client=summon |